Korean College of Rheumatology 39 th KCR Annual Scientific Meeting 1 th International Symposium May 16 Thu - 1 Sat, 2019 Seoul Dragon City, Seoul, orea 4 5 Program at a Glance ROOM

www.rheum.or.kr/kcr2019

39th Korean College of Rheumatology Annual Scientific Meeting and 13th International Symposium

May 16 (Thu.) - 18 (Sat.), 2019Seoul Dragon City, Seoul, Korea

PROGRAM BOOK

39th KCR Annual Scientific Meeting 13th International Symposium

May 16 (Thu.) - 18 (Sat.), 2019 Seoul Dragon City, Seoul, Korea

3Welcome Address from the President

Won ParkPresident

Korean College of Rheumatology

Dear Friends and Colleagues,

On behalf of the Korean College of Rheumatology (KCR), I am pleased to invite you to the 39th KCR Annual Scientific Meeting and the 13th International Symposium to be held at the Seoul Dragon City, Seoul, Korea from May 16 to 18, 2019.

I appreciate the chair of the scientific committee for the arrangement of the instructive programs. In the meeting, the world’s leading scholars and foreign guest speakers will present exciting lectures on various topics along with internationally renowned domestic speakers. Also, the KCR offers many opportunities to those who want to deliver their research at the meeting through oral presentations and poster presentations.

I am confident that the symposium will be highly rewarding for every participant and will contribute to the development of the field of ‘Rheumatology’ in Asia. The committee hopes all participants will enjoy the meeting through exchanging knowledge with global experts.

I truly hope your continued cooperation and active participation for the forthcoming event and I look forward to welcoming you to Seoul in May 2019.

Cordially yours,

04 Program at a Glance07 Scientific Program (Day 1, May 16)11 Scientific Program (Day 2, May 17)19 Scientific Program (Day 3, May 18)27 Poster Presentation47 Information - Important Events - Registration Guidelines - Location - Venue Map - Accommodation - About Yongsan - Organizing Committee - Sponsorship & Exhibition

CONTENTS

39th Korean College of Rheumatology Annual Scientific Meeting 13th International Symposium




4 5Program at a Glance

ROOM A[Grand Ballroom-Hanra A+B, 3F]

ROOM B[Grand Ballroom-Baekdu A+B, 5F]

ROOM D[Shilla Room, 3F]

DATE THURSDAY, MAY 16

ROOM

:30

8:00

9:00

Musculoskeletal UltrasoundWorkshop I

- Intermediate Course

:30

:30

10:00

:30

11:00

:30

12:00

:30

Luncheon Symposium I[English Session]

Luncheon Symposium II[English Session]

:30

Opening Ceremony

Musculoskeletal UltrasoundWorkshop II- Basic Course

13:00

14:00

Special Lectures[English Session]

Live Workshop for Basic Researchin Rheumatology:

Theory and Practice ofAnimal Models

:30

15:00

:30

16:00

Coffee Break

:30

18:00

:30

International Symposium I- Rheumatoid Arthritis

[English Session]

ARA-KCR Joint Symposium[English Session]

17:00

:30

:30

Welcome Dinner19:00



ROOM C[Grand Ballroom-Hanra C, 3F]

FRIDAY, MAY 17

Registration

Breakfast Symposium I[English Session]

Plenary Session- International Free Paper Session

[English Session]

Breakfast Symposium II[English Session]

Breakfast Symposium III

Coffee Break

Luncheon Symposium III[English Session]

International Symposium II- Gout

[English Session]

Free Paper Session IEpidemiology and Health Service

Research

Free Paper Session IISystemic Lupus Erythematosus

International Symposium III- Spondyloarthritis[English Session]

Korean Biologics RegistrySymposium

Free Paper Session III Sjögren's Syndrome, Systemic

Sclerosis, and Inflammatory Myositis

Luncheon Symposium IV[English Session]

Luncheon Symposium V[English Session]

Poster Viewing and Coffee Break

Medical Humanities Symposium Medical Ethics: Now and Future in Korea

International Symposium IV- Osteoporosis

[English Session]

KCR Academic Award

General Assembly

Gala Dinner



ROOM C[Grand Ballroom-Hanra C, 3F]

SATURDAY, MAY 18 DATE

ROOM

:30Registration

8:00

:30

9:00

International Symposium V- Systemic Lupus Erythematosus

[English Session]

Free Paper Session IVOsteoarthritis and Orthopedics

[English Session]

Free Paper Session VIIRheumatoid Arthritis Basic Research

Breakfast Symposium IVBreakfast Symposium V

[English Session]Breakfast Symposium VI

:30

10:00

:30

Coffee Break11:00

:30

12:00

:30

International Symposium VI- Sjögren's Syndrome

[English Session]

Free Paper Session VSpondyloarthritis

Free Paper Session VIIIRheumatoid Arthritis Clinical Research

13:00

:30

International Symposium VII- Systemic Sclerosis

[English Session]

Luncheon Symposium VI[English Session]

Luncheon Symposium VII[English Session]

Luncheon Symposium VIII

Free Paper Session VIVasculitis and Miscellaneous

Free Paper Session IXRheumatoid Arthritis Treatments

14:00

:30

15:00

Poster Viewing & Coffee Break :30

16:00

:30

18:00

International Symposium VIII- Vasculitis

[English Session]

Rheumatology ResearchFoundation Symposium

Free Paper Session XMetabolic and Crystal Arthropathies,

Fibromyalgia, and PediatricRheumatology

:30

17:00

:30

:30

19:00

Closing Ceremony

Award Session- Young Investigator Award- Best Oral Presentation Award- Best Poster Presentation Award


6

DAY 1 PROGRAMMay 16 (Thu.)


Cosimo De BariUniv. of Aberdeen,

UK

Hyon K. ChoiHarvard Medical School,

USA

Masayoshi HarigaiTokyo Women’s Medical Univ.,

Japan

Yannick AllanoreParis Descartes Univ.,

France

Robert ColbertNIAMS,

USA

Nigil HaroonUniv. of Toronto,

Canada

Betty DiamondThe Feinstein Institute for Medical Research,

USA

Marvin J. Fritzler The Univ. of Calgary,

Canada

Andrea DoriaUniv. of Padova,

Italy

Josef SmolenMedical Univ. of Vienna,

Austria

Jacob M. van LaarUniv. Medical Centre Utrecht,

Netherlands

Anke RoelefsUniv. of Aberdeen,

UK

Robert TerkeltaubUCSD,USA

Hisashi YamanakaTokyo Women’s Medical Univ.,

Japan

Augusto VaglioUniv. of Firenze,

Italy

Janet PopeUniv. of Western Ontario,

Canada

Athanasios G TzioufasUniv. of Athens,

Greece

Rikard HolmdahlKarolinska Institute,

Sweden

Stephen P. McAdooImperial College London,

UK

Marco Matucci CerinicUniv. of Florence,

Italy

Denis PoddubnyyCharité Universitätsmedizin Berlin,

Germany

Michael R McClungOregon Osteoporosis Center,

USA

Nancy E. LaneUC Davis,

USA

Jacques-Olivier PersBrest Univ.,

France

Wan-Fai NgNewcastle Univ.,

UK

Matthew A. BrownQueensland Univ. of Technology,

Australia

David NichollsCoast Joint Care,

Australia

Invited Faculty

Scientific Program Day 1 (May 16) Day 2 (May 17) Day 3 (May 18)

Special Lectures

International Symposium- Rheumatoid Arthritis

International Symposium- Gout- Spondyloarthritis- Osteoporosis

International Symposium- Systemic Lupus Erythematosus- Sjögren’s Syndrome- Systemic Sclerosis- Vasculitis

Symposium- ARA-KCR Joint Symposium

Symposium- Korean Biologics Registry Symposium- Medical Ethics: Now and Future in Korea

Symposium- Rheumatology Research Foundation Symposium

Workshop- Live Workshop for Basic Research in

Rheumatology- Musculoskeletal Ultrasound Workshop I- Musculoskeletal Ultrasound Workshop II

Free Paper Session - International Free Paper Session- Epidemiology and Health Service Research- Systemic Lupus Erythematosus- Sjögren’s Syndrome, Systemic Sclerosis, and

Inflammatory Myositis

Free Paper Session - Osteoarthritis and Orthopedics- Spondyloarthritis- Vasculitis and Miscellaneous - Rheumatoid Arthritis Basic Research- Rheumatoid Arthritis Clinical Research- Rheumatoid Arthritis Treatment- Metabolic and Crystal Arthropathies,

Fibromyalgia, and Pediatric Rheumatology




8 9

» ROOM A [Grand Ballroom-Hanra A+B, 3F] » ROOM B [Grand Ballroom-Baekdu A+B, 5F]» ROOM C [Grand Ballroom-Hanra C, 3F] » ROOM D [Shilla Hall, 3F]

Day 1. May 16 (Thu.)

12:30-13:30Luncheon Symposium I – Amgen Future Directions in Osteoporosis TherapeuticsChair: Won Park (Inha Univ., Korea)

ROOM A

Optimizing osteoporosis management in the short and long-termMichael R McClung (Oregon Osteoporosis Center, USA)

14:00-16:00 Special LecturesChairs: Soo-Kon Lee (Cha Univ., Korea), Dae Hyun Yoo (Hanyang Univ., Korea)ROOM A

14:00-15:00 Meet the Editor-in-Chief of Annals of the Rheumatic Diseases: Editorial policy and recent hot topicsJosef Smolen (Medical Univ. of Vienna, Austria)

15:00-16:00 Meet the Editor-in-Chief of Rheumatology: Editorial policy and recent hot topicsJacob M. van Laar (Univ. Medical Centre Utrecht, Netherlands)

16:00-16:30 Coffee Break

16:30-18:00 International Symposium I – Rheumatoid ArthritisChairs: Ho-Youn Kim (The Catholic Univ., Korea), Bin Yoo (Univ. of Ulsan, Korea)ROOM A

16:30-17:00 Molecular analysis and functional role of antibodies to citrullinated proteins Rikard Holmdahl (Karolinska Institutet, Sweden)

17:00-17:30 Joint-resident mesenchymal stem cells in joint health and cartilage repairAnke Roelefs (Univ. of Aberdeen, UK)

17:30-18:00 Mesenchymal stem cells in arthritis: The good or bad guys?Cosimo De Bari (Univ. of Aberdeen, UK)

12:30-13:30Luncheon Symposium II IL-6 Inhibition Leads NewsChair: Seung-Jae Hong (Kyung Hee Univ., Korea)

ROOM B

IL-6 inhibition in rheumatoid arthritis and other connective tissue diseasesYuko Kaneko (Keio Univ., Japan)

14:00-16:00Live Workshop for Basic Research in Rheumatology: Theory and Practice of Animal ModelsChairs: Gwan Gyu Song (Korea Univ., Korea), Sang-Il Lee (Gyeongsang Nat’l Univ., Korea)

Experimental animal models for osteoporosis

14:00–14:25 Theory and applicationsChang Hoon Lee (Wonkwang Univ., Korea)

14:25–14:50 Methods and assessment of osteoporosis animal models Sung Chul Kwak (Wonkwang Univ., Korea)

14:50–15:00 Q&A

Experimental animal models for Sjögren’s Syndrome

15:00–15:25 Introduction of animal models of Sjögren's Syndrome: General concept and application in translational researchSeung-Ki Kwok (The Catholic Univ., Korea)

15:25–15:50 Methods and assessmentJaeseon Lee (The Catholic Univ., Korea)

15:50–16:00 Q&A


16:30-18:00 ARA-KCR Joint SymposiumChairs: Sung-Hwan Park (Chairman of the board, KCR), David Nicholls (President, ARA)

16:30-16:50 The Australian Rheumatology Association Database (ARAD) and the Australian Arthritis and Autoimmune Diseases Biobank Collaborative (A3BC)David Nicholls (President, ARA)

16:50-17:10 The Korean College of Rheumatology Biologics and Targeted Therapy Registry (KOBIO): Our future directives Kichul Shin (Seoul Nat’l Univ., Korea)

17:10-17:30 Improving diagnostic approaches in axial spondyloarthritisMatthew A. Brown (Queensland Univ. of Technology, Australia)

17:30-17:50 Apolipoprotein B regulates inflammation via enolase-1 in inflammatory arthritisYeong Wook Song (Seoul Nat’l Univ., Korea)

Korean Session English Session

ROOM B

ROOM B

E

E

E

E

E

K

EK


10


09:00-12:00 Musculoskeletal Ultrasound Workshop I - Intermediate Course ROOM D

09:00–11:00 제1세션: 강의 – 근골격초음파 표준 영상 및 평가 교육 좌장: 윤종현(가톨릭의대)

09:00-09:30 관절, 힘줄, 부착부 염증평가 - 표준 영상과 척도김현옥(경상의대)

09:30-10:00 골, 연골, 힘줄 손상평가 - 표준 영상과 척도김재훈(고려의대)

10:00-10:30 초음파를 이용한 류마티스관절염 활성도평가 체계이상훈(경희의대)

10:30-11:00 근골격초음파 표준 영상 시연 (RA환자, OA환자) 송 란(경희의대)

11:00–12:00 제2세션: 실습 – 근골격초음파 표준 영상 실습 좌장: 김해림(건국의대)

근골격초음파 표준 영상 실습 (RA환자, OA환자)

실습강사: 김재훈(고려의대), 김현아(아주의대), 송 란(경희의대), 이창훈(원광의대)

13:30-16:30 Musculoskeletal Ultrasound Workshop II - Basic Course ROOM D

13:30-15:00 제1세션: 근골격 초음파 기본영상 - 상지좌장: 홍승재(경희의대)

13:30-14:00 상지의 초음파 표준 영상 소개이연아(경희의대)

14:00-15:00 실습 – 어깨와 수부관절 초음파 영상 획득하기실습강사: 문수진(가톨릭의대), 백인운(가톨릭의대), 이경언(순천향의대), 정주양(아주의대)

15:00–16:30 제2세션: 근골격 초음파 기본영상 – 하지좌장: 김현숙(순천향의대)

15:00-15:30 하지의 초음파 표준 영상 소개김윤성(조선의대)

15:30-16:30 실습 – 무릎과 발목관절 초음파 영상 획득하기실습강사: 박윤정(가톨릭의대), 이진희(가톨릭의대),이주하(가톨릭의대), 주영빈(가톨릭의대)

DAY 2 PROGRAMMay 17 (Fri.)


K

K

Korean Session English SessionEK




12 13


Day 2. May 17 (Fri.)

08:00-08:50Breakfast Symposium I – Abbvie Recent Updates for Achieving Clinical Remission in RAChair: Soo-Kon Lee (Cha Univ., Korea)

ROOM A

Outcomes assessment: Assets, fallacies and the influence of disease durationJosef Smolen (Medical Univ. of Vienna, Austria)

09:00–10:30 Plenary Session - International Free Paper Session Chairs: Yeong-Wook Song (Seoul Nat’l Univ., Korea), Eun-Mi Koh (Sungkyunkwan Univ., Korea)

PS-001 RKIP suppresses inflammatory responses and bone destruction in human fibroblast-like synoviocytes and in mice with collagen-induced arthritisHae Sook Noh (Gyeongsang Nat'l Univ., Korea)

PS-002 Understanding how viruses cause arthritisSuresh Mahalingam (Griffith Univ., Australia)

PS-003 Selective estrogen receptor modulator lasofoxifene suppresses spondyloarthritis manifestation and affects characteristics of gut microbiota in zymosan-Induced SKG miceHyemin Jeong (Soonchunhyang Univ., Korea)

PS-004 Influence of genetic risk variants on the clinical subphenotypes of systemic lupus erythematosus in a Korean cohortHyuk-Hee Kwon (Hanyang Univ., Korea)

PS-005 Soluble siglec-5 is a novel salivary biomarker for primary Sjögren’s SyndromeJennifer Lee (The Catholic Univ., Korea)

PS-006 Oral gene therapy of post-traumatic osteoarthritis with gut macrophage-targeted delivery of IL-1β ShRNA via recombinant sacchromyces cerevisiaeQian Chen (Brown Univ., USA)

PS-007 Efficacy and safety of the novel oral Janus Kinase (JAK) inhibitor, peficitinib, in a phase 3, double-blind, placebo-controlled, randomized study of patients with RA with an inadequate response to DMARDsYeong-Wook Song (Seoul Nat'l Univ., Korea)

PS-008 A phase III randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on SoC in patients with active class III or IV lupus nephritisMary A Dooley (Univ. of North Carolina at Chapel Hill, USA)


11:00–12:30 International Symposium II - Gout Chairs: Jung-Yoon Choe (Catholic Univ. of Daegu, Korea), Jung-Soo Song (Chung-Ang Univ., Korea)

11:00-11:30 Translational advances in understanding gouty synovitisRobert Terkeltaub (UCSD, USA)

11:30-12:00 Tackling the modern gout epidemic - Advances in the prevention and management of goutHyon K. Choi (Harvard Medical School, USA)

12:00-12:30 Current strategy for gout and hyperuricemia - Treat early and treat to targetHisashi Yamanaka (Tokyo Women’s Medical Univ., Japan)

12:30-13:30Luncheon Symposium III – Lilly Why EULAR Recommends JAK Inhibitors for RA Treatment?Chair: Dae Hyun Yoo (Hanyang Univ., Korea)

ROOM A

Benefit of baricitinib, a JAK1/2 selective inhibitor, for managing RA and enhancing patient's QoLRieke Alten (Univ. Medicine Berlin, Germany)

13:30-15:00 International Symposium III - Spondyloarthritis Chairs: Tae-Hwan Kim (Hanyang Univ., Korea), Yong-Gil Kim (Univ. of Ulsan, Korea)ROOM A

13:30-14:00 HLA-B27 and Gut Microbiota in Spondyloarthritis: The Complexities of DysbiosisRobert Colbert (NIAMS, USA)

14:00-14:30 Imaging in axial spondyloarthritisDenis Poddubnyy (Charité Universitätsmedizin Berlin, Germany)

14:30-15:00 State of the art: Treatment of axial spondyloarthritisNigil Haroon (Univ. of Toronto, Canada)

15:00-16:00 Poster Viewing and Coffee Break [5F, Exhibition Hall]

16:00-17:30 International Symposium IV - Osteoporosis Chairs: Won Park (Inha Univ., Korea), Sang-Heon Lee (Konkuk Univ., Korea) ROOM A

16:00-16:30 The role of CrkII in bone metabolismNacksung Kim (Chonnam Nat'l Univ., Korea)

16:30-17:00 Evaluating the effects of therapeutic agents for osteoporosis and utility of tests for diagnosis and monitoring the diseaseMichael R McClung (Oregon Osteoporosis Center, USA)

17:00-17:30 Glucocorticoid induced osteoporosis: The science and therapyNancy E. Lane (UC Davis, USA)


ROOM A

ROOM A

E

E

E

E

E

E




14 15


08:00-08:50Breakfast Symposium II – PfizerNew Era of Juvenile Rheumatic Disease TreatmentChair: Kwang-Nam Kim (Hallym Univ., Korea)

ROOM B

An introduction to JIA Nicolino Ruperto (Univ. of Genoa, Italy)


11:00-12:30 Free Paper Session I – Epidemiology and Health Service Research Chairs: Young-Ho Lee (Korea Univ., Korea), Seong-Kyu Kim (Catholic Univ. of Daegu, Korea)

O17-001 Risk of malignancies in patients with gout: A national wide population-based study in KoreaHyun Ah Lee (Asan Medical Center, Korea)

O17-002 Malignancy risk in male patients with ankylosing spondylitisBora Nam (Hanyang Univ., Korea)

O17-003 Temporal relationship between idiopathic inflammatory myopathies and malignancies and its mortality: A nationwide population-based studyYoon-Kyoung Sung (Hanyang Univ., Korea)

O17-004 Risk-benefit analysis of primary prophylaxis for pneumocystis pneumonia using trimethoprim-sulfamethoxazole in patients with rheumatic diseases exposed to prolonged, medium-dose glucocorticoidsJun Won Park (Seoul Nat'l Univ., Korea)

O17-005 Comparison of risk for infection-related hospitalization and associated costs of biologic experienced rheumatoid arthritis patients treated with abatacept versus other targeted disease modifying antirheumatic drugsDamemarie Paul (Bristol-Myers Squibb, USA)

O17-006 The relationship between hyperuricemia and heart rate irregularity, using data from the Korean National Health and Nutrition Examination Survey 2016Yeonghee Eun (Sungkyunkwan Univ., Korea)

O17-007 Comorbidity, medication use, and pregnancy rate among Korean women with rheumatoid arthritis in childbearing years based on the national health insurance service dataMin Kyung Chung (Ewha Womans Univ., Korea)

O17-008 Lupus is a risk factor for poor outcomes and higher healthcare utilization after total hip arthroplastyJasvinder Singh (Univ. of Alabama at Birmingham, USA)

12:30-13:30Luncheon Symposium IV - LGOptimizing Rheumatoid Arthritis Management in the Short and Long TermChair: Yeong-Wook Song (Seoul Nat’l Univ., Korea)

ROOM B

Trend of RA management in Japan - Lesson learned from IORRA cohortHisashi Yamanaka (Tokyo Women’s Medical Univ., Japan)

13:30-15:00 Korean Biologics Registry SymposiumChairs: Shin-Seok Lee (Chonnam Nat’l Univ., Korea), Yong-Beom Park (Yonsei Univ., Korea)

13:30-13:45 KOBIO 2019 updateKichul Shin (Seoul Nat’l Univ., Korea)

13:45-14:00 Adverse events of interest captured in KOBIO rheumatoid arthritis patientsHyoun-Ah Kim (Ajou Univ., Korea)

14:00-14:15 Medical Dictionary for Regulatory Activities (MedDRA) and its integration into KOBIOKichul Shin (Seoul Nat’l Univ., Korea)

14:15-14:30 The effect of biologic disease modifying anti-rheumatic drugs on hypertension in patients with rheumatoid arthritis: Data from KOBIO RegistrySeong-Kyu Kim (Catholic Univ. of Daegu, Korea)

14:30-14:45 Glucocorticoid sparing effect of targeted therapy in rheumatoid arthritis: Real-world data from the KOBIOEunyoung Emily Lee (Seoul Nat’l Univ., Korea)

14:45-15:00 Effect of drug adherence on treatment outcome in rheumatoid arthritis (KORONA)Kiwon Moon (Kangwon Nat'l Univ., Korea)


ROOM B

ROOM B


E E

EK

K




16 17


08:00-08:50Breakfast Symposium III - CelltrionEvolution in the Management of Rheumatic DiseasesChair: Sang-Hoon Lee (Kyung Hee Univ., Korea)

ROOM C

Past, present and future of infliximab in rheumatic diseasesChang-Nam Son (Keimyung Univ., Korea)

11:00–12:30 Free Paper Session II – Systemic Lupus Erythematosus Chairs: Chang-Hee Suh (Ajou Univ., Korea), Hye-Soon Lee (Hanyang Univ., Korea)ROOM C

O17-009 Bach2-deficient B cells produce IgG autoantibodies pathogenic for lupus nephritis through T-dependent extrafollicular pathwayEunkyeong Jang (Hanyang Univ., Korea)

O17-010 Mesenchymal stem cells ameliorate atherosclerosis and lupus through promoting Tr1 cellsShiying Wang (Nanjing Univ. Medical School, China)

O17-011 Salivary immunoglobulin gamma-3 chain C in systemic lupus erythematosusJu-Yang Jung (Ajou Univ., Korea)

O17-012 New organ involvement development during follow-up of patients with systemic lupus erythematosus in China: A Multi-center Cohort Study from CSTAR RegistryZiqian Wang (Peking Union Medical College Hosp., China)

O17-013 Adherence to hydroxychloroquine influences the incidence of organ damage during follow-up in patients with systemic lupus erythematosusJi-Hyoun Kang (Chonnam Nat'l Univ., Korea)

O17-014 Recovery of renal function in patients with lupus nephritis and reduced renal functionJung Sun Lee (Univ. of Ulsan, Korea)

O17-015 Risk factors associated with thrombotic events in Korean patients with systemic lupus erythematosusDong-Jin Park (Chonnam Nat'l Univ., Korea)

O17-016 Systemic Lupus Erythematosus is associated with increased risk of Parkinson’s disease: A retrospective cohort study using Korean National Health Insurance Service databaseIn Young Kim (Nat'l Police Hosp., Korea)

12:30-13:30Luncheon Symposium V - Yuhan Biosimilar: Real World Clinical Data in EuropeChair: Seung-Cheol Shim (Chungnam Nat’l Univ., Korea)

ROOM C

Focus on switching clinical data of biosimilar in Europe Thomas Dörner (Charite Univ., Germany)

13:30-15:00Free Paper Session III - Sjögren’s Syndrome, Systemic Sclerosis, and Inflammatory Myositis Chairs: Jun-Ki Min (The Catholic Univ., Korea), Chan Hong Jeon (Soonchunhyang Univ., Korea)

O17-017 The effects of non-invasive vagus nerve stimulation on fatigue and neurocognition in participants with primary Sjögren's SyndromeJessica Tarn (Newcastle Univ., UK)

O17-018 Circulating CCR7loPD-1hi follicular helper T cells indicate disease activity and glandular inflammation in patients with primary Sjögren’s Syndrome Ji-Won Kim (The Catholic Univ., Korea)

O17-019 Distinct clinical characteristics of Anti-Ro/SSA negative primary Sjögren’s Syndrome in a prospective cohort of Korean patientsYoungjae Park (The Catholic Univ., Korea)

O17-020 Muscular expression of HLA-C and HLA-DR as useful diagnostic markers for idiopathic inflammatory myopathyByeongzu Ghang (Jeju Nat'l Univ., Korea)

O17-021 Mitochondrial transplantation suppressed muscle inflammation and improved the mitochondrial dysfunction in C protein-induced myositis model in miceJeong Yeon Kim (Seoul Nat'l Univ., Korea)

O17-022 NMR-based serum metabolomics as surrogate for disease activity in inflammatory myositisLatika Gupta (Sanjay Gandhi Postgraduate Institute of Medical Sciences, India)

O17-023 Clinical features of interstitial lung disease associated with Korean idiopathic inflammatory myopathies according to the autoantibody profileSang Wan Chung (Kyung Hee Univ., Korea)

O17-024 Endoscopic features of upper gastrointestinal tract in patients with systemic sclerosis compared to the healthy controlJun Won Park (Seoul Nat'l Univ., Korea)

ROOM C


E

EKEK

K


18


DAY 3 PROGRAMMay 18 (Sat.)


15:30-17:30 Medical Humanities Symposium - Medical Ethics: Now and Future in KoreaChairs: Choong-Ki Lee (Yeungnam Univ., Korea), Han-Joo Baek (Gachon Univ., Korea)ROOM C

15:30-16:30 Medical care and justiceIvo Kwon (Ewha Womans Univ., Korea)

16:30-17:30 Clinical ethics: Theory and practiceSang Ho Yoo (Hanyang Univ., Korea)

K

For Korean [필수과목 교육 프로그램]

[2018년 연수교육 지침 변경 주요 사항]

회원의 전문성 및 직업윤리의식 함양을 위하여 의료법 시행규칙 제20조에 의거 필수 과목 이수가 의무화 되었음.

(2018년 1월 1일부터 시행)

필수과목 연수교육 이수 의무화 시행일자: 2018. 1. 1.

- 2019년 면허 신고 대상자부터 적용.

- 일반과목 이수 외 필수과목 이수 2평점이 의무화되었음. (대상: 전문의)

(단, 3년마다 2시간 이상 이수, 2019년에 교육 이수해야 함. 면허신고자는 직전 3년간의 24평점 중 2평점을 필수교육

평점으로 이수해야 함.)

- 필수과목 교육프로그램 강의실에 별도의 입출결 관리 의무

(예: 체류시간 59분 – 평점없음. 60분 이상 – 1점 인정 / 120분 이상 – 2점 인정)

※ 필수과목 교육 프로그램이란?

: 의료윤리, 의료법령 주요 위반사례, 의료감염관리, 의약품 부작용사례, 의료분쟁사례 등 직종별 특성을 감안한 자체

교육프로그램

[의료 정책 심포지엄 – 필수 과목 교육 프로그램]

· 사전 등록 시, 신청하여 주십시오. (*선착순 200名)

· 필수평점: 2평점

· 일시: 2019년 5월 17일(금) 15:30 ~ 17:30

· 장소: 서울드래곤시티 3F, Room C (그랜드볼룸 한라홀 C)

※ 필수과목은 입출결 체크를 강의장 앞에서 별도로 진행합니다.

[평점안내]

· 대한의사협회 16일: 4평점, 17일 : 6평점 (필수교육 의료윤리 2평점), 18일: 6평점

· 대한내과학회 관절류마티스내과: 2평점

· 대한내과학회 내과 전공의 외부학술회의: 2평점

- 1일 2평점 인정

- 국내개최 국제학술대회: 개최기간에 관계없이 2평점 인정




20 21


Day 3. May 18 (Sat.)

08:00-08:50Breakfast Symposium IV - YuhanManagement of Rheumatoid Disease Patient with Biosimilar Chair: Jung-Soo Song (Chung-Ang Univ., Korea)

ROOM A

The effectiveness and Safety of BiosimilarYoon-Kyoung Sung (Hanyang Univ., Korea)

09:00–10:30 International Symposium V - Systemic Lupus ErythematosusChairs: Sang-Cheol Bae (Hanyang Univ., Korea), Jisoo Lee (Ewha Womans Univ., Korea)ROOM A

09:00-09:30 Autoreactive B cells in SLEBetty Diamond (The Feinstein Institute for Medical Research, USA)

09:30-10:00 Rethinking ANA testing in SLE: Where have we come from and where are we going?Marvin J. Fritzler (The Univ. of Calgary, Canada)

10:00-10:30 Novel strategies in systemic lupus erythematosus managementAndrea Doria (Univ. of Padova, Italy)


11:00–12:30 International Symposium VI - Sjögren’s SyndromeChairs: Sung-Hwan Park (The Catholic Univ., Korea), Yun Jong Lee (Seoul Nat'l Univ., Korea)ROOM A

11:00-11:30 Sjögren’s Syndrome: The clinical picture and predictive factors for the development of lymphoma Athanasios G Tzioufas (Univ. of Athens, Greece)

11:30-12:00 Molecular approaches to the definition of disease subsets in Sjögren’s SyndromeJacques-Olivier Pers (Brest Univ., France)

12:00-12:30 Therapeutic advances in primary Sjögren's SyndromeWan-Fai Ng (Newcastle Univ. UK)

12:30-13:30Luncheon Symposium VI – AbbvieQuality of Care in SpondyloarthritisChair: Tae-Hwan Kim (Hanyang Univ., Korea)

ROOM A

Optimizing care for SpA patients by addressing contemporary challenges: TNFi vs IL-17iDenis Poddubnyy (Charité Universitätsmedizin Berlin, Germany)

13:30-15:00 International Symposium VII - Systemic SclerosisChairs: Eun-Bong Lee (Seoul Nat’l Univ., Korea), Hyun-Sook Kim (Soonchunhyang Univ., Korea)

13:30-14:00 Organ complication of SSc, relevance to a clinical trialJanet Pope (Univ. of Western Ontario, Canada)

14:00-14:30 Management of skin problems in SSc (Scleroderma, digital ulcer, calcification)Marco Matucci Cerinic (Univ. of Florence, Italy)

14:30-15:00 SSc-associated vs idiopathic pulmonary hypertensionYannick Allanore (Paris Descartes Univ., France)


16:00-17:30 International Symposium VIII – VasculitisChairs: Seung-Cheol Shim (Chungnam Nat’l Univ., Korea), Chan-Bum Choi (Hanyang Univ., Korea)

16:00-16:30 Current and future treatments for ANCA-associated vasculitisStephen P McAdoo (Imperial College London, UK)

16:30-17:00 Advance in clinical management of large vessel vasculitisMasayoshi Harigai (Tokyo Women's Medical Univ., Japan)

17:00-17:30 Eosinophilic granulomatosis with polyangiitis Augusto Vaglio (Univ. of Firenze, Italy)

08:00-08:50Breakfast Symposium V - AstellasILD with Rheumatoid ArthritisChair: Shin-Seok Lee (Chonnam Nat’l Univ., Korea)

ROOM B

Diagnosis and treatment for ILD with rheumatoid arthritis patientsYasuhiko Yamano (Tosei General Hosp., Japan)

09:00–10:30 Free Paper Session IV - Osteoarthritis and OrthopedicsChairs: Gun-Il Im (Dongguk Univ., Korea), Hyun Sik Gong (Seoul Nat’l Univ., Korea)ROOM B

O18-025 MSC exosomes attenuate inflammation and restore matrix homeostasis in osteoarthritisShipin Zhang (Nat'l Univ. of Singapore, Singapore)

O18-026 A critical role for TGFβ1-mediated Stat3 activation in endochondral ossification in miceMin-Su Han (Daegu Fatima Hosp., Korea)

O18-027 Expression of microRNA-892b in human mesenchymal stem cells promotes cartilage regeneration in arthymic nude rat osteochondral defect modelJeong-Won Park (Dongguk Univ., Korea)

O18-028 CCL17 blockade as a therapy for osteoarthritis pain and diseaseMing-Chin Lee (The Univ. of Melbourne, Australia)

O18-029 The morphology of proximal tibiofibular joint (PTFJ) predicts incident radiographic medial osteoarthritis: Data from Osteoarthritis InitiativeZhaohua Zhu (Zhujiang Hosp. of Southern Medical Univ., China)

ROOM A


K

E

E

E

E

E

E

E

ROOM A




22 23


13:30-15:00 Free Paper Session VI - Vasculitis and MiscellaneousChairs: Geun-Tae Kim (Kosin Univ., Korea), Sang-Won Lee (Yonsei Univ., Korea)ROOM B

O18-041 Clinical features in elderly patients with antineutrophil cytoplasmic antibody-associated vasculitisByung-Woo Yoo (Yonsei Univ., Korea)

O18-042 Risk factors associated with Peripheral Neuropathy (PN) in ANCA-Associated Vasculitis (AAV)Luis Felipe Flores-Suárez (Instituto Nacional de Enfermedades Respiratorias, Mexico)

O18-043 Serum interleukin-21 positivity could indicate the current activity of antineutrophil cytoplasmic antibody-associated vasculitis: A monocentric prospective studySung Soo Ahn (Yonsei Univ., Korea)

O18-044 The clinical features and risk factors of parenchymal neuro-Behcet’s diseaseWenjie Zheng (Peking Union Medical College Hosp., China)

O18-045 Leflunomide in combination with glucocorticoids is superior to conventional glucocorticoids monotherapy in preventing relapse in IgG4-related disease: A randomized, open-label, controlled trialYiwen Wang (Chinese PLA General Hosp., China)

O18-046 Detrimental factors affecting clinical relapse in Korean patients with polymyalgia rheumatica during their first-year treatmentYoon-Jeong Oh (Kangwon Nat'l Univ., Korea)

O18-047 Distinct clinical features of Connective Tissue Disease Associated Interstitial Lung Disease (CTD-ILD) according to the time of developing ILDSang Wan Chung (Kyung Hee Univ., Korea)

O18-048 Differential diagnosis of patients with high serum level of ferritin: A single-center experience from a tertiary care instituteSeung Min Jung (Yonsei Univ., Korea)


16:00-17:30 Rheumatology Research Foundation SymposiumChairs: Won Tae Chung (Dong-A Univ., Korea), Sung Jae Choi (Korea Univ., Korea)ROOM B

16:00-16:20 Hospitalization of patients with rheumatic diseases on immune modulating agentsSeonghoon Park (Catholic Univ. of Daegu, Korea)

16:20-16:40 Role of Eotaxin (CCL11) in the pathogenesis of new bone formation in ankylosing spondylitisSeung-Geun Lee (Pusan Nat’l Univ., Korea)

16:40-17:00 Development of a novel therapy for chronic tophaceous gout using uricase producing mesenchymal stem cellsJooha Lee (The Catholic Univ., Korea)

17:00-17:20 Hypoxia inducible factor in rheumatoid arthritisSu-Jin Yoo (Chungnam Nat'l Univ., Korea)

17:20-17:30 Q&A

O18-030 Serum adiponectin and radiological features of osteoarthritis in the knee and hand: The Dong-gu StudyXu Haimuzi (Chonnam Nat'l Univ., Korea)

O18-031 Is there a relationship between lateral epicondylitis and total cholesterol levels?Seung Hoo Lee (Seoul Nat'l Univ., Bundang Hosp., Korea)

O18-032 Diffuse idiopathic skeletal hyperostosis is a new risk factor for vertebral fracture in older men – the prospective MINOS studyPawel Szulc (Univ. of Lyon, Hôpital Edouard Herriot, France)


11:00–12:30 Free Paper Session V - SpondyloarthritisChairs: Kun Woo Kim (Daegu Fatima Hosp., Korea), Myeung Su Lee (Wonkwang Univ., Korea)

O18-033 Intracellular protein phosphatase magnesium-dependent 1A regulates inflammasome activationOh Chan Kwon (Univ. of Ulsan, Korea)

O18-034 Serum miR-3620-3p as a noninvasive biomarker for ankylosing spondylitisTaejong Kim (Chonnam Nat'l Univ., Korea)

O18-035 MicroRNA-451 suppresses inflammatory responses in ankylosing spondylitis by targeting macrophage migration inhibitory factorMin-Chan Park (Yonsei Univ., Korea)

O18-036 Long-term treatment with tumor necrosis factor inhibitors is associated with a reduction in the rate of radiologic progression in patients with ankylosing spondylitisBon San Koo (Inje Univ., Korea)

O18-037 Shifting toward Th17 by allograft inflammatory factor-1 contributes to poor response to TNF inhibitor in ankylosing spondylitisJeong Seok Lee (KAIST, Korea)

O18-038 Alcohol consumption as a predictor of the progression of spinal structural damage in axial spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO)Hong Ki Min (The Catholic Univ., Korea)

O18-039 Bony bridge on facet joint or lateral side of lumbar vertebra is more frequent and correlated with lumbar flexion function than that on anterior side in ankylosing spondylitisSo Yun Lee (Kyung Hee Univ., Korea)

O18-040 Pregnancy outcome and the change of treatment after delivery in ankylosing spondylitis using the Korean Health Insurance Review and Assessment Service claims databaseJung Sun Lee (Univ. of Ulsan, Korea)

12:30-13:30Luncheon Symposium VII - NovartisAdvanced Treatment in Axial SpAChair: Sang-Heon Lee (Konkuk Univ., Korea)

ROOM B

Optimal clinical approach in axial SpA: Why & How?Atul A. Deodhar (Oregon Health and Science Univ., USA)

ROOM B


E

E

K

K

K




24 25


O18-059 Gender differences in clinical characteristics and comorbidities and their impact on clinical outcome in Korean patients with rheumatoid arthritisSeunghwan Shin (Seoul Nat'l Univ., Korea)

O18-060 Establishment of a prospective cohort for rheumatoid arthritis patients with interstitial lung disease: comparison of clinical characteristics between rheumatoid arthritis patient with and without interstitial lung diseaseJuyeon Kang (Hanyang Univ., Korea)

O18-061 Respiratory viral infection and the risk of rheumatoid arthritis: A time-series analysisYoung Bin Joo (The Catholic Univ., Korea)

O18-062 Sleep disorder or depression in Korean rheumatoid arthritis, and its association with disease activityKyeong Min Son (Hallym Univ., Korea)

O18-063 The correlation between the ultrasound-detected synovitis of small joints and the disease activity in patients with rheumatoid arthritisXiaoying Sun (Peking Univ. First Hosp., China)

O18-064 Effect of treat-to-target strategy on disease activity and radiologic outcomes in rheumatoid arthritis: Results from a 9-year Chinese CohortLanlan Ji (Peking Univ. First Hosp., China)

O18-065 The Comparative Risk of osteoporotic fractures among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: A nation-wide Cohort Study in KoreaAnna Shin (Seoul Nat'l Univ., Bundang Hosp., Korea)

12:30-13:30Luncheon Symposium VIII - Pfizer RA Treatment Strategy with New Treatment OptionChair: Bin Yoo (Univ. of Ulsan, Korea)

ROOM C

The first oral JAK inhibitor, tofacitinib for RA treatmentEun-Bong Lee (Seoul Nat’l Univ., Korea)

13:30-15:00 Free Paper Session IX - Rheumatoid Arthritis TreatmentChairs: Jinseok Kim (Jeju Nat’l Univ., Korea), Chang Keun Lee (Univ. of Ulsan, Korea)ROOM C

O18-066 Overexpression of direct bone morphogenetic protein/Smad target gene inhibitory B upon BMP treatment is insufficient to prevent and treat inflammatory arthritisOlexandr Korchynskyi (Rzeszów Univ., Poland)

O18-067 Human turbinate-derived mesenchymal stem cells attenuate rheumatoid inflammation in miceJaeseon Lee (The Catholic Univ., Korea)

O18-068 Treatment patterns among patients with rheumatoid arthritis treated with a biologic disease-modifying anti-rheumatic drug or JAK Inhibitor: A Nation-Wide Study in KoreaMin Jung Kim (Seoul Nat'l Univ., Korea)

O18-069 Adherence to methotrexate is associated with persistent disease activity during follow-up for rheumatoid arthritisJi-Hyoun Kang (Chonnam Nat'l Univ., Korea)

08:00-08:50Breakfast Symposium VI – Lilly Optimize RA Treatment with Oral JAK 1&2 InhibitorChair: Sung-Hwan Park (The Catholic Univ., Korea)

ROOM C

Why baricitinib, a selective JAK1/2 inhibitor, is important for RA management and what is the best strategy for baricitinib?Seung-Ki Kwok (The Catholic Univ., Korea)

09:00–10:30 Free Paper Session VII - Rheumatoid Arthritis Basic ResearchChairs: Young Mo Kang (Kyungpook Nat’l Univ., Korea), Wan-Uk Kim (The Catholic Univ., Korea)

O18-049 IL-6 and IL-17 mediated chemokine inducer is present in fibroblast like synoviocytes of patients with reactive arthritisSandeep Kumar (SGPGIMS, India)

O18-050 The pathogenic impact of CD4+ T cell-mediated cytokines, IFN - γ and IL-17A, in early stage of ACPA-positive rheumatoid arthritisKijun Lee (The Catholic Univ., Korea)

O18-051 Mesenchymal stem cells-derived secretome suppresses chronic inflammation in collagen-induced arthritis miceChin Hee Mun (Yonsei Univ., Korea)

O18-052 Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritisLei Dang (Hong Kong Baptist Univ., China)

O18-053 Bifidobacterium bifidum ATT attenuates autoimmune arthritis via regulation of Th17 and treg balanceJoo-Yeon Jhun (The Catholic Univ., Korea)

O18-054 Protective effect of protocatechuic acid rich fraction of trianthema portulacastrum against collagen induced rheumatoid arthritis via gut microbiota modulationEkta Yadav (SHUATS, India)

O18-055 Identification of CJ-15314, a novel JAK1 selective inhibitor, for the treatment of rheumatoid arthritisSo Young Ki (CJ Healthcare, Korea)

O18-056 4-Phenylbutyric acid attenuates the severity of collagen-induced arthritis in mice via inhibition of proliferation and inflammatory responses of synovial fibroblastsYunjung Choi (Chonbuk Nat'l Univ., Korea)

O18-057 Cyanidin inhibits IL-17 induced fibroblast-like synoviocytes activation in rheumatoid arthritis via IL-17RA/JAK-STAT signaling cascadeMahaboobkhan Rasool (Vellore Institute of Technology, India)

11:00-12:30 Free Paper Session VIII - Rheumatoid Arthritis Clinical ResearchChairs: Seong Wook Kang (Chungnam Nat’l Univ., Korea), Young-Il Seo (Hallym Univ., Korea)

O18-058 Association of serum KL-6 level and change of pulmonary function in interstitial lung disease of rheumatoid arthritis - Data from prospective Korean Rheumatoid Arthritis Interstitial Lung disease (KORAIL) studyJeong Seok Lee (Seoul Nat'l Univ., Korea)

ROOM C

ROOM C


K

K

EK

EK

EK


26


O18-070 Comparison of clinical characteristics and therapeutic responses of tofaticitinib in RA patients according to previous DMARDs use Hyoungyoung Kim (Hanyang Univ., Korea)

O18-071 Association between tofacitinib-based therapy for immune-mediated inflammatory diseases and cardiovascular events: a meta-analysis of randomized controlled trialsWenhui Xie (Peking Univ. First Hosp., China)

O18-072 Retention rate and safety of biosimilar CT-P13 in patients with rheumatoid arthritis: Data from the Korean College of Rheumatology biologics registryHyoun-Ah Kim (Ajou Univ., Korea)

O18-073 withdrawal


16:00-17:30Free Paper Session X - Metabolic and Crystal Arthropathies, Fibromyalgia, and Pediatric RheumatologyChairs: Chan Hee Lee (NHIC Ilsan Hosp., Korea), Sung Won Lee (Dong-A Univ., Korea)

ROOM C

O18-074 Altered distribution and enhanced osteoclastogenesis of mucosal-associated invariant T cells in gouty arthritisHae-Seong Jeong (Chonnam Nat'l Univ., Korea)

O18-075 MicroRNA-223 suppresses gouty inflammation by targeting the NLRP3 inflammasomeYu-Feng Qing (Sichuan Univ., China)

O18-076 Association of serum uric acid level with cardiovascular and renal risk in Korean adults: The Korea National Health and Nutrition Examination Survey (2016)Seung Yun Lee (Inha Univ., Korea)

O18-077 Pilot study: Asymptomatic hyperuricemia patients with obesity and non-alcoholic fatty liver disease have increased risk of double contour signHong Ki Min (The Catholic Univ., Korea)

O18-078 Impact of continuous allopurinol use on risks of cardiovascular events and all-cause mortality in gout patientsIn Ah Choi (Chungbuk Nat'l Univ., Korea)

O18-079 The impact of urate-lowering therapy on renal function in gout patientsWoo-Joong Kim (Chung-Ang Univ., Korea)

O18-080 Cryopyrin-associated periodic Syndrome: Clinical characteristics in single center experienceYoung Ho Kim (Seoul Nat'l Univ., Korea)

O18-081 Preliminary assessment of predictors for short term outcome in fibromyalgia: A single center experienceHyun-Seung Yoo (Hanyang Univ., Korea)

POSTER PRESENTATION


EK





28 29

No. Title Presenter Name

P17-001 Clinical manifestations of Behçet's disease in a large cohort of Chinese patients: Gender- and age-related differencesChaoran Li (Peking Union Medical College Hosp., China)

P17-002 Angiographic pattern and change of arterial lesion in patients with Behcet’s diseaseSu Jin Choi (Univ. of Ulsan, Korea)

P17-003 Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behcet’s uveitisJing Shi (Peking Union Medical College Hosp., China)

P17-004 Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet’s diseaseJinjing Liu (Peking Union Medical College Hosp., China)

P17-005 Aneurysmal lesions in Behcet’s disease: A report of 69 cases from a single centerJiaxin Zhou (Peking Union Medical College Hosp., China)

P17-006 A potential next generation sclerostin inhibitor specifically targets sclerostin monomer for bone anabolic therapy with low cardiovascular risk to reverse established osteoporosis in ovariectomized ratsQing Ren (Hong Kong Baptist Univ., China)

P17-007 C/EBPβ is a novel transcriptional mediator of 1,25-inducible SOST expressionSungsin Jo (Hanyang Univ., Korea)

P17-008 Serial administration of rhBMP-2 and alendronate enhance differentiation of osteoblastic MC3T3-E1 cellsHye-Jung Choi (Keimyung Univ., Korea)

P17-009 Anti-arthritic effect of Solid Lipid nanoparticle of hesperidine against Complete freund’s adjuvant induced arthritis in rats via inhibition of inflammatory mediatorsDeeksha Chauhan (Allahabad Univ., India)

P17-010 TNF-alpha inhibition improves chondrocytes viability and cartilage characteristics in in vitro studiesEmanuele Chisari (Univ. of Catania, Italy)

P17-011 Role of interleukin-11 in systemic sclerosis: A pilot studyIn Ah Choi (Chungbuk Nat'l Univ., Korea)

P17-012 Clinical significance of serum caspase-1 in patients with inflammatory arthropathiesHye-Jin Jeong (Keimyung Univ., Korea)

P17-013 Factorial validity of the WHOQOL-BREF in patients with osteoarthritis and its measurement equivalence across genderPatrick Brzoska (Witten/Herdecke Univ., Germany)

P17-014 withdrawal

Poster Presentation No. Title Presenter NameP17-015 Relationship between coffee consumption and serum uric acid level in the general Korean

population: A nationwide studyJae Hyun Jung (Korea Univ., Korea)

P17-016 The impact of change in Korean National Health Insurance reimbursement criteria for anti-TNFα agents on treatment pattern, drug persistence and remission rate in patients with rheumatoid arthritisHan-Na Lee (Pusan Nat'l Univ., Korea)

P17-017 Does anti-citrullinated protein antibody status modify treatment effect of certain biologic DMARDs?Evo Alemao (Bristol-Myers Squibb, USA)

P17-018 Patients’ perceptions of biologic therapy in KoreaIn Ah Choi (Chungbuk Nat'l Univ., Korea)

P17-019 Women with metabolic Syndrome and general obesity are at higher risk for significant hyperuricemia than menIn Young Kim (Nat'l Police Hosp., Korea)

P17-020 The relationship between serum uric acid and pulmonary function in Korean adult population: Data from the Korea National Health and Nutrition Examination SurveyHyemin Jeong (Soonchunhyang Univ., Korea)

P17-021 Prevalence and incidence of rheumatoid arthritis among Korean women in childbearing years based on the National Health Insurance Service DataMin Kyung Chung (Ewha Womans Univ., Korea)

P17-022 The impact of the urate-lowering therapy on work productivity and activity impairment in patients with goutYoung Sun Suh (Gyeongsang Nat'l Univ., Korea)

P17-023 Qualitative cross-country comparison of healthcare affecting systemic lupus erythematosus in asia-pacific regionChan-Bum Choi (Hanyang Univ., Korea)

P17-024 Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real worldYoon-Kyoung Sung (Hanyang Univ., Korea)

P17-025 Validation of Korean Version of the Lupus Patient Reported Outcome Tool (LupusPRO)Jung-Yong Han (Hanyang Univ., Korea)

P17-026 Association between anemia and hyperuricemia: Korean National Health and Nutrition Survey 2016-2017Yeonghee Eun (Sungkyunkwan Univ., Korea)

P17-027 Demographic and socioeconomic trends in health care outcomes among patients with arthropathies, dorsopathies and soft tissue disorders in germanyPatrick Brzoska (Witten/Herdecke Univ., Germany)

May 17 (Fri.)




30 31


P17-028 High serum uric acid level is associated with greater handgrip strength in the aged populationJennifer Lee (The Catholic Univ., Korea)

P17-029 Public Awareness of Rheumatoid Arthritis in MongoliaLkham-Erdene Byambadoo (Mongolian Nat'l Univ., Mongolia)

P17-030 Protective effect of magnoflorine with hyaluronic acid gel on cartilage degeneration in a rat model of ACLT induced osteoarthritisZhe Cai (The Univ. of Hong Kong, China)

P17-031 Effect of arctium lappa linne (Burdock) root tea consumption on inflammatory status and oxidative stress in patients with knee osteoarthritisLeila Maghsoumi-Norouzabad (Ahvaz Jundishapur Univ., Iran)

P17-032 Effect of Arctium Lappa Linne (Burdock) Root Tea Consumption on Clinical Signs and Symptoms in Patients with Knee OsteoarthritisReza Abed (Tabriz Univ., Iran)

P17-033 Effect of arctium lappa linne (Burdock) root tea consumption on lipid profile and blood pressure in patients with knee osteoarthritisLeila Maghsoumi-Norouzabad (Ahvaz Jundishapur Univ., Iran)

P17-034 Degrading products of chondroitin sulfate can induce hypertrophy-like changes and MMP-13/ADAMTS5 production in chondrocytesSeungwoo Han (Kyungpook Nat'l Univ., Korea)

P17-035 SIRT1 protects against osteoarthritis by inhibiting NLRP3 inflammasome activationSang Yeob Lee (Dong-A Univ., Korea)

P17-036 Hyaluronic Acid (Hi-Flex) study in the treatment of osteoarthritis of the knee joint in UzbekistanMirzakhamdam Nasirov (Tashkent Medical Academy, Uzbekistan)

P17-037 New results of the alflutop injection osteoarthritis (OA) of the knee joint in republic rheumatology center of UzbekistanMirzakhamdam Nasirov (Tashkent Medical Academy, Uzbekistan)

P17-038 New long-term effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee joint in UzbekistanJamshid Sadikov (Tashkent Medical Academy, Uzbekistan)

P17-039 Analysis of osteoarthritis management tactics in the republic of TajikistanSurayo Shukurova (Postgraduate Medical Institute of Tajikistan, Tajikistan)

P17-040 The role of DNA methylation and DNA methyltransferase 1-alpha in bone healthZhila Maghbooli (Tehran Univ., Iran)

P17-041 Trabecular bone score is a useful parameter for the prediction of vertebral fractures in patients with polymyalgia rheumaticaHyoun-Ah Kim (Ajou Univ., Korea)


P17-042 Effectiveness of bazedoxifene in the prevention of glucocorticoid-induced bone loss in RA patientsSoo-Kyung Cho (Hanyang Univ., Korea)

P17-043 A 30-year retrospective study on causes of death in childhood-onset Systemic Lupus Erythematosus in a tertiary care center, Southern ThailandPrayong Vachvanichsanong (Prince of Songkla Univ., Thailand)

P17-044 Clinical profile, long term follow-up and outcome of juvenile Systemic Sclerosis from a Single Centre Cohort in North IndiaAnkur Kumar (Postgraduate Institute of Medical Education and Research, India)

P17-045 Estimation of complementary regulatory protein CD46 and CD55 in patients with pediatric-onset Systemic Lupus Erythematous: A preliminary studyRakesh Kumar (Postgraduate Institute of Medical Education and Research, India)

P17-046 Serum soluble CD25 is a useful biomarker of macrophage activation Syndrome in systemic juvenile idiopathic arthritis: an experience at Chandigarh, IndiaSandesh Guleria (Postgraduate Institute of Medical Education and Research, India)

P17-047 Clinico-laboratory profile of macrophage activation Syndrome in children with systemic juvenile idiopathic arthritisSandesh Guleria (Postgraduate Institute of Medical Education and Research, India)

P17-048 Childhood systemic lupus erythematosus: Experience from sub-himalayan region of north-west IndiaAvinash Sharma (Dr Rajendra Prasad Government Medical College, India)

P17-049 Long-term Outcome of Children with Juvenile Dermatomyositis: A Single-Centre Study from North IndiaAvinash Sharma (Post Graduate Institute of Medical Education and Research, India)

P17-050 Clinical manifestations of childhood-onset SLE presenting with cytopenia in single instituteWoosuck Suh (The Catholic Univ., Korea)

P17-051 Clinical spectrum of childhood artritis: Experience from a single centre in sub-himalayan region in north-west IndiaGurlal Singh (Dr. Rajendra Prasad Government Medical College, India)

P17-052 Prognostic factors of clinical outcome in juvenile idiopathic arthritis patients in IndonesiaTita Luthfia Sari (Brawijaya Univ., Indonesia)

P17-053 Kawasaki disease in older children: A single centre experience from north-west IndiaRakesh Kumar (Postgraduate Institute of Medical Education and Research, India)

P17-054 Kawasaki disease shock Syndrome - more common than we think. Our experience at Chandigarh, North India Rakesh Kumar (Postgraduate Institute of Medical Education and Research, India)

P17-055 Imaging of coronary arteries in children with Kawasaki disease: Is 2D echocardiography really the gold standard?Himanshi Chaudhary (Postgraduate Institute of Medical Education and Research, India)




32 33


P17-056 Magnetic resonance imaging changes in shoulder joint in children with juvenile idiopathic arthritisMurugan Sudhakar (Postgraduate Institute of Medical Education and Research, India)

P17-057 14-3-3 eta protein, a promising step forward in predicting response to Infliximab and its biosimilar? Results from two groups of patients diagnosed with rheumatoid arthritis in RomaniaBogdan Ion Gavrila (Carol Davila Univ., Romania)

P17-058 Could a noncollagenous extracellular matrix glycoprotein help us predicting the response to anti-TNF α therapy in Rheumatoid Arthritis?Claudia Silvia Ciofu (Carol Davila Univ., Romania)

P17-059 Prolonged and simultaneous release of methotrexate and teriflunomide in rat knee joint from CD44-targeted hydroxyapatite nanoparticles to treat rheumatoid arthritisShweta Pandey (School of Pharmaceutical Education and Research, India)

P17-060 The effect of Janus kinase inhibitors therapies for rheumatoid arthritis on cardiovascular events: A meta-analysis of randomized controlled trialsWenhui Xie (Peking Univ., China)

P17-061 Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trialsYoung Ho Lee (Korea Univ., Korea)

P17-062 A multinational randomized placebo-controlled phase III clinical trial of M2000 (β-D-Mannuronic Acid), as a new anti-inflammatory drug in rheumatoid arthritisAbbas Mirshafiey (Tehran Univ., Iran)

P17-063 Association between Janus kinase inhibitors therapies for rheumatoid arthritis and venous thromboembolism events: A meta-analysis of randomized controlled trialsWenhui Xie (Peking Univ., China)

P17-064 The effect of drug β-D-mannuronic acid on chemokine ligands/receptors gene expression in rheumatoid arthritis patientsMona Aslani (Tehran Univ., Iran)

P17-065 Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and D-mannitolPankajkumar Yadav (SHUATS, India)

P17-066 The oral administration influence of drug β-D-mannuronic acid on the major inflammatory molecules in rheumatoid arthritis patientsSaiede Omidian (Tehran Univ., Iran)

P17-067 Comparative effectiveness in pain and HAQ-DI improvement for baricitinib (BARI) versus adalimumab (ADA), tocilizumab (TCZ), and tofacitinib (TOFA) monotherapies in csDMARD-naïve rheumatoid arthritis (RA) patients: A Matching-adjusted Indirect Comparison (MAIC)Jeong-A Lee (Lilly Korea, Korea)

P17-068 Baricitinib: Early vs delayed start in patients with rheumatoid arthritis Jeong-A Lee (Lilly Korea, Korea)

P17-069 Tocilizumab-induced thrombocytopenia in patients with rheumatoid arthritisJung Sun Lee (Univ. of Ulsan, Korea)


P17-070 The long-term outcome of Intra-articular glucocorticoids injection on radiographic joint damages in patients with Rheumatoid arthritis: A real world data from a single centerJung Hee Koh (The Catholic Univ., Korea)

P17-071 Safety and efficacy of filgotinib in Asian patients with active rheumatoid arthritis and prior inadequate response or intolerance to biologic DMARDs (bDMARD-IR) enrolled in a global phase 3 trialEun-Bong Lee (Seoul Nat'l Univ., Korea)

P17-072 Adherence to methotrexate in rheumatoid arthritis: Factors beyond direct costSanket Shah (Jawaharlal Institute of Postgraduate Medical Education and Research, India)

P17-073 Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: A meta-analysis of randomized controlled trialsYanrong Huang (Peking Univ., China)

P17-074 The immunosuppressive drug, β-D-mannuronic acid (M2000) is able to modify the level of the production of sexual hormones in rheumatoid arthritis patientsLaleh Sharifi (Tehran Univ., Iran)

P17-075 The efficacy and safety evaluation of a new immunomodulatory drug, guluronic acid (G2013) in a randomized, controlled clinical trial on rheumatoid arthritis patientsAbbas Mirshafiey (Tehran Univ., Iran)

P17-076 Effect of Novel Immunomodulator, Alpha-L-Guluronic Acid (G2013) on Toll-Like Receptor 2 and 4 in Human Peripheral Blood Mononuclear CellsSaied Bokaie (Univ. of Tehran, Iran)

P17-077 Secretome of adipose-derived mesenchymal stem cells exerts immunomodulatory properties via M2 macrophage polarizationTaejun Yoon (Yonsei Univ., Korea)

P17-078 Comparative Analysis of herpes zoster infection according to treatment modality: Real world experience from HIRA databaseBong-Woo Lee (The Catholic Univ., Korea)

P17-079 Development and optimization of teriflunomide loaded nanoliposomes for treatment of rheumatoid arthritis: A pharmacological approachNishant Rai (V. P. Chest Institute, India)

P17-080 Nanoarchitectures in management of rheumatoid arthritis: An expending horizonVijay Mishra (Lovely Professional Univ., India)

P17-081 The role of peripheral blood CD19 + B cells FOXO1 mRNA and miR-155 from patients with systemic lupus erythematosusLi Jin (Univ. of Science and Technology of China, China)

P17-082 Influence of genetic variants on avascular necrosis in patients with systemic lupus erythematosusHyuk-Hee Kwon (Hanyang Univ., Korea)

P17-083 High levels anti-dsDNA in SLE subjects: It’s relations with CMV infection and memory T-cellsPerdana Aditya Rahman (Universitas Brawijaya, Indonesia)




34 35


P17-084 Integrative analysis of functional research of genetic polymorphisms of MFG-E8 gene in Korean patients with systemic lupus erythematousInok Son (Ajou Univ., Korea)

P17-085 Combination treatment with Lactobacillus acidophilus and tacrolimus have potent therapeutic efficacy and improves tacrolimus induced Th17/Treg cell imbalance in animal model of lupusDa Som Kim (The Catholic Univ., Korea)

P17-086 Impact of stringent complete renal response on long-term renal outcomes in proliferative lupus nephritisJebum Won (Univ. of Ulsan, Korea)

P17-087 Effect of drug α-L-guluronic acid on chemokine receptors expression profile in patients with systemic lupus erythematosusFariba Mokhtarian (Tehran Univ., Iran)

P17-088 PD-L1 expressing myeloid-derived suppressor cells (MDSCs) have potent immuoregulatory activity and control lupus-like autoimmunityMin-Jung Park (The Catholic Univ., Korea)

P17-089 Mindfulness-based cognitive therapy in Korean patients with systemic lupus erythematosusJi-Won Kim (Ajou Univ., Korea)

P17-090 Metformin enhances immunomodulatory effects of adipose-derived mesenchymal stem cells : Therapeutic potential of metformin-treated Ad-MSCs in animal model of lupusSe Gwang Jang (The Catholic Univ., korea)

P17-091 Treatment outcome in lupus nephritis patients treated with mycophenolate mofetil: From a real-world clinical practiceSeung Min Jung (Yonsei Univ., Korea)

P17-092 Cold compress from cassava as an innovative stress therapy to prevent exacerbations and improve quality of life of lupus patientsElvira Sari Dewi (Universitas Brawijaya, Indonesia)

P17-093 Atializumab, a humanized anti-aminoacyl-tRNA synthetases-interacting multifunctional protein-1 (AIMP1) monoclonal antibody significantly improves nephritis in (NZB/NZW) F1 MiceChin Hee Mun (Yonsei Univ., Korea)

P17-094 Mesenchymal stem cells-derived secretome attenuates inflammation in NZB/W F1 mice by modulating helper T cell responseChin Hee Mun (Yonsei Univ., Korea)

P17-095 Clinical significance of serum IL-10 and IL-33 in patients with SLEXuan Fang (The First Affiliated Hosp. of USTC, China)

P17-096 Altered expression of the three lncRNAs in PBMCs might be involved the pathogenesis of ankylosing spondylitisQuan-Bo Zhang (Affiliated Hosp. of North Sichuan Medical College, China)

P17-097 The propensity to fat metaplasia of sacroiliac joint in spondyloarthropathy : results from the single regional center cohortSang Yeob Lee (Dong-A Univ., Korea)


P17-098 Predictors of ASAS health index in axial spondyloarthritis: Data from the Catholic Axial Spondyloarthritis Cohort (CASCO)Hong Ki Min (The Catholic Univ., Korea)

P17-099 Effect of anti-tumor necrosis factor therapy on sclerostin and dickkopf-1 in ankylosing spondylitisMin Wook So (Pusan Nat'l Univ., Korea)

P17-100 Efficacy and safety of a potent and highly selective oral tyrosine kinase 2 inhibitor, BMS-986165, in patients with moderate-to-severe plaque psoriasis: A phase II, randomized, placebo-controlled trialKenneth B Gordon (Medical College of Wisconsin, USA)

P17-101 Inhibition of the TLR/ NF-kB signaling pathway by M2000, as a novel NSAID, in ankylosing spondylitis patientsMaryam Roozbehkia (Tehran Univ., iran)

P17-102 Immunomodulatory effects of the new NSAID guluronic acid (G2013) on Immunological and Inflammatory Determinants in a Clinical Trial on Patients with Ankylosing SpondylitisSeyed Shahabeddin Mortazavi-Jahromi (Tehran Univ., Iran)

P17-103 A Randomized Controlled Clinical Trial for Evaluating the Safety and Efficacy of G2013 (Guluronic acid) in Patients with Ankylosing SpondylitisSanaz Afraei (Tehran Univ., Iran)

P17-104 Differential proteomic analysis of synovial fluid from ankylosing spondylitis and other rheumatic diseasesJi-Hyun Lee (Keimyung Univ., Korea)

P17-105 Differences in the risk of tuberculosis among tumor necrosis factor inhibitors in patients with ankylosing spondylitisBon San Koo (Inje Univ., Korea)

P17-106 Intra-articular Sacroiliac Corticosteroid Injections in Ankylosing SpondylitisBora Nam (Hanyang Univ., Korea)

P17-107 The role of mannuronic acid (M2000) on treg and Th17 following the oral administration of this drug in ankylosing spondylitis patientsSoheil Najafi (Tehran Univ., Iran)

P17-108 Phase II, randomized clinical trial of beta-D-mannuronic acid for efficacy and safety in patients with ankylosing spondylitisSoheil Najafi (Tehran Univ., Iran)

P17-109 Single center experience with SAPHO in locomotor pain clinic at the university hospitalSeung Mi Yeo (Sungkyunkwan Univ., Korea)

P17-110 The frequency of peripheral features in Korean ankylosing spondylitis patients and the effectiveness of adalimumabSang-Hoon Lee (Kyung Hee Univ., Korea)

P17-111 Correlation between the radiological severity of the spine (mSASSS) and the involvement in hip joint and sacroiliac joint in ankylosing spondylitis patientsJuyeon Kang (Hanyang Univ., Korea)




36 37


P17-112 The diagnostic value of the four lncRNAs in ankylosing spondylitisQuan-Bo Zhang (Affiliated Hosp. of North Sichuan Medical College, China)

P17-113 A rare pulmonary complication of Behcet’s disease: Recurrent spontaneous pneumothoraxWonkyo Yi (Chonbuk Nat'l Univ., Korea)

P17-114 Rapid destructive osteoarthritis on the knee, presumed the cause of disease maybe the single use of intra-articular lidocaine and triamcinolone injection in rheumatoid arthritis patient with sustained clinical remissionSang Yeob Lee (Dong-A Univ., korea)

P17-115 Severe pulmonary complication in systemic juvenile idiopathic arthritis (SJIA): An emerging problem in the biological eraAssunta Chi Hang Ho (Chinese Univ. of Hong Kong, China)

P17-116 Severe myositis mimicking juvenile dermatomyosistis as the presenting clinical manifestation of Kawasaki disease in a young boyAnkur Kumar (Postgraduate Institute of Medical Education and Research, India)

P17-117 A unique combination of nail changes in a boy with Kawasaki diseaseAnkur Kumar (Postgraduate Institute of Medical Education and Research, India)

P17-118 Recurrent lupus mesenteric vasculitis: A clinical oddity!Pratap Patra (Postgraduate Institute of Medical Education and Research, India)

P17-119 Neuromyelitis optica and juvenile dermatomyositis: Overlap of two rare and disabling autoimmune conditions in a young boyHimanshi Chaudhary (Postgraduate Institute of Medical Education and Research, India)

P17-120 Two siblings with vision loss and an uncommon vasculitisMurugan Sudhakar (Postgraduate Institute of Medical Education and Research, India)

P17-121 Cold agglutinin disease presenting as peripheral gangreneMurugan Sudhakar (Postgraduate Institute of Medical Education and Research, India)

P17-122 Camptodactyly-arthropathy-coxavara-pericarditis Syndrome: Report of a novel variant from IndiaGurlal Singh (Dr.Rajendra Prasad Government Medical College, India)

P17-123 A case of classic pachydermodactyly presenting as polyarthritisKwang Nam Kim (Hallym Univ., Korea)

P17-124 A 9 month-old boy with C2 deficiency presenting refractory Kawasaki disease with giant coronary aneurysmSoo-Young Lee (The Catholic Univ., Korea)

P17-125 Successful treatment of Felty’s Syndrome-associated severe neutropenia with rituximab: A case reportHyun-Seung Yoo (Hanyang Univ., Korea)

P17-126 Delayed hypersensitivity reactions to adalimumab in a patient with rheumatoid arthritis successfully treated with immunoglobulinMihye Kwon (Konyang Univ., Korea)

P17-127 A case of psoriatic spondylitis mimicking spinal metastasisEun Young Ahn (Pusan Nat'l Univ., Korea)

P17-128 A rare presentation of myositis as a variant of morpheaKyung Ah Kim (Sungkyunkwan Univ., Korea)

No. Title Presenter NameP18-129 American college of rheumatology classification criteria for fibromyalgia are less sensitive

among sub-Saharan African patientsRichard Oluyinka Akintayo (Univ. of Ilorin Teaching, Nigeria)

P18-130 The association between body composition and fatigue in patients with fibromyalgia; higher fatigue score in FM patients was associated with lower skeletal muscle mass indexJi Hyun Lee (Maryknoll Medical Center, Korea)

P18-131 Association of SUDOSCAN values with disease duration in female patients with fibromyalgiaSu-Jin Moon (The Catholic Univ., Korea)

P18-132 Assessment of the most distal sensory nerves in fibromyalgia patients with normal routine nerve conduction studySu-Jin Moon (The Catholic Univ., Korea)

P18-133 Clinical characteristics and quality of life of patients with comorbid fibromyalgia and axial spondyloarthritis: a cross-sectional study of a Chinese populationXiaojian Ji (Chinese PLA General Hosp., China)

P18-134 The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patientsBlanka Stiburkova (Charles Univ. and General Univ., Czech Republic)

P18-135 Butyrophilin-like protein 2 variants associate with diverse Asian populations of rheumatoid arthritis independently from HLA-DRB1 shared epitope alleles: Results from the MyEIRA studyChun Lai Too (Karolinska Institutet and Karolinska Univ. Hosp., Malaysia)

P18-136 HLA class II amino acid variants associations in rheumatoid arthritis: Findings from the MyEIRA population-based case control studyLay Kim Tan (Universiti Kuala Lumpur Royal, Malaysia)

P18-137 Ultrasound-detected joint inflammation can identify patients with high bone erosion burden and disease activity using an extended 36-joint ultrasonography in rheumatoid arthritisYork Kiat Tan (Nat'l Univ. of Singapore, Singapore)

P18-138 Radiologic features in symptomatic/asymptomatic heels of patients with ankylosing spondylitisIl-Hoon Sung (Hanyang Univ., Korea)

P18-139 Time-course of major salivary glands in primary Sjögren’ Syndrome: Longitudinal ultrasound studyKyung-Ann Lee (Soonchunhyang Univ., Korea)

P18-140 Antibodies to anti-arbovirus in rheumatoid arthritis: Data from the MyEIRA population based case-control studyLay Kim Tan (Kuala Lumpur Univ. Royal College of Medicine Perak, Malaysia)

P18-141 Prevalence and risk factors for hyperuricemia in Russian patients with abdominal obesityIvan Pchelin (Saint Petersburg State Univ., Russia)

P18-142 Gout and the risk of Parkinson’s disease in older adults: A study of U.S. medicare dataJasvinder Singh (Univ. of Alabama, USA)

P18-143 Risk factors of uric acid deposition in gout patients by ultrasonographyYu Wang (First Hosp. of Peking Univ., China)

May 18 (Sat.)Poster Presentation




38 39

No. Title Presenter NameP18-144 Change of ultrasonographic signs during urate lowering therapy in patients with gout

Yu Wang (First Hosp. of Peking Univ., China)P18-145 Association of microRNA-146a rs57095329 Polymorphism with Susceptibility to Primary Gout in

a Chinese Han PopulationYu-Feng Qing (Sichuan Univ., China)

P18-146 Tophi, a predictive factor of arterial stiffness in patients with gout and hyperuricemiaWoo Seong Jeong (Jeju Nat'l Univ., Korea)

P18-147 The association of serum uric acid levels and the risk of lower urinary tract symptomsJoong Kyong Ahn (Sungkyunkwan Univ., Korea)

P18-148 A survey for diagnosis and treatment of patients with gout in KoreaMi Ryoung Seo (Gachon Univ., Korea)

P18-149 Clinical features and risk factors of tophi development in 1237 gout patientsYu-Feng Qing (Affiliated Hosp. of North Sichuan Medical College, China)

P18-150 High serum uric acid level is associated with lower incidence of osteoporosis in postmenopausal women: Data from the Korean National Health and Nutrition Examination SurveyEun-Jung Park (Nat'l Medical Center, Korea)

P18-151 Adipokine as a link between obesity and younger age-onset goutHyun-Ok Kim (Gyeongsang Nat'l Univ., Korea)

P18-152 An Analysis of the Clinical Features of Malignancy in Patients with Connective Tissue Diseases Associated Interstitial Lung DiseaseChih-Wei Liu (Taipei Veterans General Hosp., Taiwan)

P18-153 withdrawalP18-154 Clinical characteristics of seven relapsing polychondritis patients misdiagnosed as arthritis

Xiaoyu Cao (Peking Union Medical College Hosp., China)P18-155 withdrawalP18-156 Transfersomal gel of valdecoxib mitigates complete Freund's adjuvant (CFA) induced arthritis in

rats via suppression of COX-1, COX-2, and TNF-Α: Novel delivery system for rheumatoid arthritisDeepika Singh (SHUATS, India)

P18-157 Two-year efficacy and safety of ixekizumab in psoriatic arthritis patientsJeong-A Lee (Lilly Korea, Korea)

P18-158 Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with current disease activity in polymyalgia rheumaticaJu-Yang Jung (Ajou Univ., Korea)

P18-159 Myopenia is a independent risk factor for rotator cuff tear and shoulder dysfunction: Data from NAMGARAM CohortYun Hong Cheon (Gyeongsang Nat'l Univ., Korea)

P18-160 The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still’s diseaseMi-Hyun Ahn (Ajou Univ., Korea)

No. Title Presenter NameP18-161 Risk factors for development of connective tissue disease in idiopathic pulmonary fibrosis

Byeongzu Ghang (Jeju Nat'l Univ., Korea)P18-162 Investigating the role of transforming growth factor-beta and fatigue in chronic fatigue

SyndromeBethany Dibnah (Newcastle Univ., UK)

P18-163 Epidemiological profile of sarcoidosis in South Indian scenarioShyamala C (Apollo BGS Hosp., India)

P18-164 Non-inflammatory arthropathy of childhood – A case series from IndiaPratap Patra (Postgraduate Institute of Medical Education and Research, India)

P18-165 Prognostic factors predicting the survival of patients with macrophage activation SyndromeSeung Min Jung (Yonsei Univ., Korea)

P18-166 Treatment of high-risk patients with macrophage activation SyndromeSeung Min Jung (Yonsei Univ., Korea)

P18-167 Clinical features of rheumatic heart diseases in population of TajikistanFarzona Qurbonova (Postgraduate Medical Institute of Tajikistan, Tajikistan)

P18-168 A pilot study of lung ultrasound B-lines and KL-6 in patients with idiopathic inflammatory myositis associated interstitial lung diseaseYukai Wang (Shantou Central Hosp., China)

P18-169 Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patientsXiaohui Zhang (Peking Univ., China)

P18-170 Reclassification of Korean patients with polymyositis and dermatomyositis based on the bohan and peter criteria by the 2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathiesJuyoung Yoo (Yonsei Univ., Korea)

P18-171 Autoantibody profile of children with juvenile dermatomyositis from a tertiary care centre in North IndiaDharmagat Bhattarai (Postgraduate Institute of Medical Education and Research, India)

P18-172 Distinct seasonal patterns in the onset of anti-melanoma differentiation-associated gene 5 antibody-positive idiopathic inflammatory myopathies in KoreaIn Seol Yoo (Chungnam Nat'l Univ., Korea)

P18-173 Effectiveness of psycho-education on depression and anxiety symptoms in perimenopausal women with lower limb fractures: An interventional studyAgila Chandran (Sri Venkateshwaraa Medical College Hosp. and Research Centre, India)

P18-174 14-3-3η protein in serum and synovial fluid correlates with radiographic damage and progression in a longitudinal evaluation of patients with established rheumatoid arthritisNevin Hammam (Univ. of Alberta, Canada)

P18-175 Cysteine rich 61 (Cyr61): A biomarker reflecting disease activity in rheumatoid arthritisYong Fan (Peking Univ., China)




40 41

No. Title Presenter NameP18-176 Predictors of persistent disease activity in patients with early rheumatoid arthritis in the first

year of tight control and aggressive therapyWenhui Xie (Peking Univ., China)

P18-177 Assessing rates of early remission and identifying its predictors in rheumatoid arthritis on the basis of various validated indices: Results from a 10-year Chinese cohortWenhui Xie (Peking Univ., China)

P18-178 Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors for treatment response and drug persistence of anti-tumor necrosis factor-α agents in patients with rheumatoid arthritisHan-Na Lee (Pusan Nat'l Univ., Korea)

P18-179 A cross sectional observational study on correlation of sex hormones with disease activity in premenopausal females with rheumatoid arthritis at a tertiary care centre, New Delhi, IndiaPulin Kumar Gupta (Dr RML Hosp., India)

P18-180 Swelling or tenderness, which one corresponds better with ultrasound-detected synovitis in rheumatoid arthritis?Xiaoying Sun (Peking Univ., China)

P18-181 The agreement between ultrasound-determined joint inflammation and clinical signs in patients with rheumatoid arthritisXiaoying Sun (Peking Univ., China)

P18-182 Bone mineral density and microarchitecture among Chinese patients with rheumatoid arthritisShangyi Jin (Peking Union Medical College Hosp., China)

P18-183 Influence of rheumatoid arthritis on childbirth and neonatal outcome among Korean Women in childbearing years: A population data based on the national health insurance service dataJin-Su Park (Nat'l Health Insurance Service Ilsan Hosp., Korea)

P18-184 Impact of the presence of bronchiectasis on treatment and disease activity in patients with rheumatoid arthritisHyoungyoung Kim (Hanyang Univ., Korea)

P18-185 New study on endothelial dysfunction in patients with rheumatoid arthritis in UzbekistanJamshid Sadikov (Tashkent Medical Academy, Uzbekistan)

P18-186 Study on cardiovascular system lesions in patients with rheumatoid arthritis in UzbekistanRustam Rashidov (Tashkent Medical Academy, Uzbekistan)

P18-187 Features of quality of life in patients with rheumatoid arthritis associated with cardiovascular pathologyRustam Rashidov (Tashkent Medical Academy, Uzbekistan)

P18-188 Difference in clinical relevance of anti-carbamylated protein antibody in rheumatoid arthritis in Asians and CaucasiansJung Yoon Pyo (Yonsei Univ., Korea)

P18-189 Immunomodulatory effect of dietary pulses in collagen induced rheumatoid arthritisHelen Antony Pillai (Univ. of Kerala, India)

No. Title Presenter NameP18-190 Cellular and soluble CD23 are potent biomarkers for monitoring rheumatoid arthritis disease

activitiesSin-Yeang Teow (Sunway Univ., Malaysia)

P18-191 Investigation of toll-like receptor (TLR)4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drugKyoung Soo Kim (Kyung Hee Univ., Korea)

P18-192 The production of mitochondrial reactive oxygen species from regulatory T cells are correlated with the disease activity of rheumatoid arthritisHa-Reum Lee (Chungnam Nat'l Univ., Korea)

P18-193 Analysis of periodontitis and subgingival microbiome in patients with pre-rheumatoid arthritisJi-Won Kim (The Catholic Univ., Korea)

P18-194 Inhibition of Oxidative phosphorylation down-regulates HMGB1 secretion by suppression of macrophage differentiationHanna Kim (Yonsei Univ., Korea)

P18-195 Bromodomain inhibitor, I-BET762 inhibits production of pro-inflammatory mediators by down-regulating bromodomain as an epigenetic reader in rheumatoid arthritis fibroblast-like synoviocytesRa-Ham Kim (Seoul Nat'l Univ., Korea)

P18-196 The impact of gender and estrogen on the function of mesenchymal stem cells in rheumatoid arthritisHyeon-Jeong Lee (Gyeongsang Nat'l Univ., Korea)

P18-197 Anti-inflammatory effects of spleen tyrosine kinase (Syk) inhibitor, piceatannol, on fibroblast-like synoviocyte in rheumatoid arthritisSeon Uk Kim (Seoul Nat'l Univ., Korea)

P18-198 Association of shared epitope and poor prognostic factors in RAEvo Alemao (Bristol-Myers Squibb, USA)

P18-199 Prominent citrullination of tracheal cartilage in cigarette smoking-aggravated collagen induced arthritisMoon Young Kim (The Catholic Univ., Korea)

P18-200 Cadherins guide the directional migration of the synoviocytes in rheumatoid arthritisJin Hee Kang (Kyungpook Nat'l Univ., Korea)

P18-201 A randomized controlled trial comparing scapulothoracic exercise & ultrasound therapy with and without maitland mobilization for the treatment of adhesive capsulitisJalpa Shah (Sri Venkateshwaraa College of Paramedicals, India)

P18-202 The innate immunity is essential for a mew mouse model of primary Sjӧgren’s SyndromeGao Yunzhen (Xinxiang Medical Univ., China)

P18-203 The histopathologic positivity has little clinical impact on anti-Ro/SSA-positive primary Sjögren’s Syndrome patients in KoreaYoungjae Park (The Catholic Univ., Korea)




42 43

No. Title Presenter NameP18-204 AIM2 inflammasome is activated in the salivary gland derived from patients with primary

Sjögren’s SyndromeHong Seung-Min (The Catholic Univ., Korea)

P18-205 At risk groups in primary Sjögren's Syndrome: Longitudinal data on quality of lifeJessica Tarn (Newcastle Univ., UK)

P18-206 Pregnancy outcomes in patients with Sjögren Syndrome: Clinical outcome of an Italian CohortMaddalena Larosa (Univ. of Padova, Italy)

P18-207 Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s SyndromeEmmanuella Young Traianos (Newcastle Univ., UK)

P18-208 Clinical features and risk factors of pulmonary embolism in patients with systemic lupus erythematosusHanxiao You (Peking Union Medical College Hosp., China)

P18-209 Accelerated immune aging was associated with lupus-associated brain fog in reproductive- age systemic lupus erythematosus patientsHandono Kalim (Faculty of Medicine Brawijaya Univ., Indonesia)

P18-210 Pregnancy in systemic lupus eryhtematosus and Sjögren Syndrome: Differences and similarities in maternal and fetal complicationsMaddalena Larosa (Univ. of Padova, Italy)

P18-211 Clinical characteristics and remission of patients with systemic lupus erythematosus in China: Results from SLE treatment and research group (CSTAR) registry with a real-time collecting systemZiqian Wang (Peking Union Medical College Hosp., China)

P18-212 NMO spectrum disorder in adults and children with lupus- Experience from a single tertiary care center over 25 yearsLatika Gupta (Sanjay Gandhi Postgraduate Institute of Medical Sciences, India)

P18-213 Anti-smith antibody is associated with disease activity in patients with new-onset systemic lupus erythematosusSung Soo Ahn (Yonsei Univ., Korea)

P18-214 LDL-cholesterol as a risk factor of progression to ESRD in patients with lupus nephritisDong-Jin Park (Chonnam Nat'l Univ., Korea)

P18-215 Association of co-positivity for anti-dsDNA, -nucleosome, and -histone antibodies and disease activity in patients with lupus nephritis: Results from the KORNET registryDong-Jin Park (Chonnam Nat'l Univ., Korea)

P18-216 Catastrophic antiphospholipid Syndrome: Experience from a single center in ChinaCan Huang (Peking Union Medical College Hosp., China)

P18-217 Clinical characteristics of patients with systemic lupus erythematosus showing the false-positive result of syphilis testSung Soo Ahn (Yonsei Univ., Korea)

No. Title Presenter NameP18-218 Long-term outcomes in patients with proliferative lupus nephritis in association with

membranous nephropathySung Soo Ahn (Yonsei Univ., Korea)

P18-219 Causes of death in SLE: Analysis of inpatient death from 2000-2018 in a tertiary care hospital in IndiaSarit Sekhar Pattanaik (Sanjay Gandhi Post Graduate Institute of Medical Sciences, India)

P18-220 Early immunosenesence in SLE patients is associated with inflammatory processes and not with CMV infectionKusworini Handono (Faculty of Medicine Brawijaya Univ., Indonesia)

P18-221 The effect of mycophenolate mofetil on non-renal manifestations in systemic lupus erythematosus: Observation study of Korean Lupus Network (KORNET) registry from 2014 to 2018Ui Hong Jung (Catholic Univ. of Daegu, Korea)

P18-222 Risk factors for serious infections in patients with systemic lupus erythematosus: Glucocorticoid dose, serositis, and hematologic involvementJi-Won Kim (Ajou Univ., Korea)

P18-223 The discovery of LM9 as a specific biomarker in patients with systemic lup

Documents

Korean College of Rheumatology 39 th KCR Annual Scientific Meeting 1 th International Symposium May 16 Thu - 1 Sat, 2019 Seoul Dragon City, Seoul, orea 4 5 Program at a Glance ROOM